The board of directors of Johnson & Johnson (NYSE:JNJ) authorised a common stock cash dividend of USD0.84 per share for the third quarter of 2017, the company disclosed on Monday.

With an ex-dividend date of 25 August 2017, the dividend will be paid on 12 September 2017 to shareholders of record date at the close of business on 29 August 2017.

Johnson & Johnson together with its subsidiaries, researches and develops, manufactures and sells various products in the health care field worldwide. It operates through three segments: Consumer, Pharmaceutical and Medical Devices.

The company was founded in 1885 and is based in New Brunswick, New Jersey, USA.